These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8777863)

  • 1. Efficacy of intravenous immunoglobulin therapy in a case of juvenile dermatomyositis.
    Galeazzi M; Bellucci AM; Girardelli CR; Bono R; De Pita O; Puddu P
    Clin Rheumatol; 1996 Mar; 15(2):215-6. PubMed ID: 8777863
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.
    Al-Mayouf SM; Laxer RM; Schneider R; Silverman ED; Feldman BM
    J Rheumatol; 2000 Oct; 27(10):2498-503. PubMed ID: 11036850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose intravenous immunoglobulin therapy for intractable dermatomyositis skin lesions.
    Sadayama T; Miyagawa S; Shirai T
    J Dermatol; 1999 Jul; 26(7):457-9. PubMed ID: 10458087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin in juvenile dermatomyositis--four year review of nine cases.
    Sansome A; Dubowitz V
    Arch Dis Child; 1995 Jan; 72(1):25-8. PubMed ID: 7717731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute immune thrombocytopenic purpura in a 90-year-old woman treated with immunoglobulin as well as glucocorticoid.
    Kamimura T; Hatakeyama M; Torigoe K; Minota S
    Intern Med; 2003 Dec; 42(12):1265-6. PubMed ID: 14714973
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis].
    Breems DA; de Haas PW; Visscher F; Sabbe LJ; Busch HF; van Doorn PA
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1979-82. PubMed ID: 8413708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.
    Aslanidis S; Pyrpasopoulou A; Kartali N; Zamboulis C
    Clin Rheumatol; 2007 Jul; 26(7):1198-200. PubMed ID: 16779504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin therapy for refractory myositis.
    Moriguchi M; Suzuki T; Tateishi M; Hara M; Kashiwazaki S
    Intern Med; 1996 Aug; 35(8):663-7. PubMed ID: 8894745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous Immunoglobulin in Refractory Juvenile Dermatomyositis.
    de Inocencio J; Enríquez-Merayo E; Casado R; González-Granado LI
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26966131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravenous Ig therapy in juvenile dermatomyositis.
    Lam CG; Manlhiot C; Pullenayegum EM; Feldman BM
    Ann Rheum Dis; 2011 Dec; 70(12):2089-94. PubMed ID: 21978999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of dermatomyositis with the anti-signal recognition particle antibody that was successfully treated with prednisolone and intravenous immunoglobulin therapy.
    Mizumaki K; Maeda S; Ikawa Y; Matsushita T; Takehara K; Hamaguchi Y
    J Dermatol; 2019 Jul; 46(7):e251-e253. PubMed ID: 30690762
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis and therapy for polymyositis and dermatomyositis].
    Kawai S
    Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2171-6. PubMed ID: 18044152
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immunoglobulin therapy.
    Stein LD; Roifman CM
    Bull Rheum Dis; 1995 Jun; 44(4):3-5. PubMed ID: 7787963
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravenously administered immunoglobulins as a first-choice method in juvenile dermatomyositis].
    Wokke JH
    Ned Tijdschr Geneeskd; 1993 Nov; 137(48):2509-10. PubMed ID: 8272132
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous immunoglobulins in polymyositis and dermatomyositis].
    Chérin P; Herson S
    Rev Med Interne; 1999; 20 Suppl 4():436s-439s. PubMed ID: 10522319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose immunoglobulin therapy for a patient with dermatomyositis.
    Furuya Y; Takahashi T; Hamamoto H; Nishimura M; Kawakami Y
    Intern Med; 1998 Jul; 37(7):642-5. PubMed ID: 9711898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis?
    Schleinitz N; Jean E; Benarous L; Mazodier K; Figarella-Branger D; Bernit E; Veit V; Kaplanski G; Harle JR
    Clin Rheumatol; 2008 Aug; 27(8):1067-8. PubMed ID: 18463936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy.
    Mosca M; Strigini F; Carmignani A; D'ascanio A; Genazzani AR; Bombardieri S
    Arthritis Rheum; 2005 Feb; 53(1):119-21. PubMed ID: 15696574
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of early treatment with intravenous immunoglobulins in severe forms of dermatomyositis].
    Escriche D; de la Cruz J; Moreno MJ; Romero J
    Med Clin (Barc); 1995 Jan; 104(2):79. PubMed ID: 7869785
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe dermatomyositis with rhabdomyolysis and paralytic ileus: a case successfully treated with plasmapheresis and intravenous immunoglobulin.
    Fukunaga E; Kunishige M; Mitsui T; Endo I; Oshima Y; Ohnishi Y; Kuroda Y; Hara S; Matsumoto T
    Eur J Neurol; 2002 Nov; 9(6):697-8. PubMed ID: 12453096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.